Ethyl 4-(2-(4-chlorophenyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazine-1-carboxylate

Catalog No. :
ACGQBM467
CAS No. :
931728-33-5
Molecular Formula :
C19H21ClN6O2
Molecular Weight :
400.87

IUPAC Name:ethyl 4-(2-(4-chlorophenyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazine-1-carboxylate

Ethyl 4-(2-(4-chlorophenyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$702.00Login to see priceInquiryInquiry
100mg97%$1757.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-(2-(4-chlorophenyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazine-1-carboxylate
IUPAC Nameethyl 4-(2-(4-chlorophenyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazine-1-carboxylate
MDL No.MFCD14815156
Molecular FormulaC19H21ClN6O2
Molecular Weight400.87
SMILESO=C(N1CCN(C2=CC(C)=NC3=NC(C4=CC=C(Cl)C=C4)=NN23)CC1)OCC
InChI KeyKFWSZWLQTQAFDK-UHFFFAOYSA-N
SynonymEthyl 4-(2-(4-chlorophenyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[2-(4-chlorophenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-, ethyl ester
CAS No.931728-33-5

Synthetic Route by SureRoute

1. ACGQBM467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPYCL530 route compound structure diagram
    ACPYCL530120-43-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGQBM467 route product structure diagram
    ACGQBM467931728-33-5
Inquiry

2. ACGQBM467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGQBM467 route product structure diagram
    ACGQBM467931728-33-5
Inquiry

Comments (0)